Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line
A biosurfactant producing bacterium was identified as Pseudomonas aeruginosa DNM50 based on molecular characterization (NCBI accession no. MK351591). Structural characterization using MALDI-TOF revealed the presence of 12 different congeners of rhamnolipid such as Rha-C8-C8:1, Rha-C10-C8:1, Rha-C10-...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c6f867e64c444ad699994ee646e3e8d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c6f867e64c444ad699994ee646e3e8d5 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c6f867e64c444ad699994ee646e3e8d52021-12-01T18:18:03ZCharacterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line2296-418510.3389/fbioe.2021.761266https://doaj.org/article/c6f867e64c444ad699994ee646e3e8d52021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fbioe.2021.761266/fullhttps://doaj.org/toc/2296-4185A biosurfactant producing bacterium was identified as Pseudomonas aeruginosa DNM50 based on molecular characterization (NCBI accession no. MK351591). Structural characterization using MALDI-TOF revealed the presence of 12 different congeners of rhamnolipid such as Rha-C8-C8:1, Rha-C10-C8:1, Rha-C10-C10, Rha-C10-C12:1, Rha-C16:1, Rha-C16, Rha-C17:1, Rha-Rha-C10:1-C10:1, Rha-Rha-C10-C12, Rha-Rha-C10-C8, Rha-Rha-C10-C8:1, and Rha-Rha-C8-C8. The radical scavenging activity of rhamnolipid (DNM50RL) was determined by 2, 3-diphenyl-1-picrylhydrazyl (DPPH) assay which showed an IC50 value of 101.8 μg/ ml. The cytotoxic activity was investigated against MDA-MB-231 breast cancer cell line by MTT (4,5-dimethylthiazol-2-yl-2,5-diphenyl tetrazolium bromide) assay which showed a very low IC50 of 0.05 μg/ ml at 72 h of treatment. Further, its activity was confirmed by resazurin and trypan blue assay with IC50 values of 0.01 μg/ml and 0.64 μg/ ml at 72 h of treatment, respectively. Thus, the DNM50RL would play a vital role in the treatment of breast cancer targeting inhibition of p38MAPK.Neelam MishraKavita RanaSiva Deepthi SeelamRakesh KumarVijyendra PandeyBharathi P. SalimathBharathi P. SalimathDayanand AgsarFrontiers Media S.A.articleMDA-MB-231 cell linesrhamnolipidMTTtrypan bluep38MAPKTNBCBiotechnologyTP248.13-248.65ENFrontiers in Bioengineering and Biotechnology, Vol 9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
MDA-MB-231 cell lines rhamnolipid MTT trypan blue p38MAPK TNBC Biotechnology TP248.13-248.65 |
spellingShingle |
MDA-MB-231 cell lines rhamnolipid MTT trypan blue p38MAPK TNBC Biotechnology TP248.13-248.65 Neelam Mishra Kavita Rana Siva Deepthi Seelam Rakesh Kumar Vijyendra Pandey Bharathi P. Salimath Bharathi P. Salimath Dayanand Agsar Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line |
description |
A biosurfactant producing bacterium was identified as Pseudomonas aeruginosa DNM50 based on molecular characterization (NCBI accession no. MK351591). Structural characterization using MALDI-TOF revealed the presence of 12 different congeners of rhamnolipid such as Rha-C8-C8:1, Rha-C10-C8:1, Rha-C10-C10, Rha-C10-C12:1, Rha-C16:1, Rha-C16, Rha-C17:1, Rha-Rha-C10:1-C10:1, Rha-Rha-C10-C12, Rha-Rha-C10-C8, Rha-Rha-C10-C8:1, and Rha-Rha-C8-C8. The radical scavenging activity of rhamnolipid (DNM50RL) was determined by 2, 3-diphenyl-1-picrylhydrazyl (DPPH) assay which showed an IC50 value of 101.8 μg/ ml. The cytotoxic activity was investigated against MDA-MB-231 breast cancer cell line by MTT (4,5-dimethylthiazol-2-yl-2,5-diphenyl tetrazolium bromide) assay which showed a very low IC50 of 0.05 μg/ ml at 72 h of treatment. Further, its activity was confirmed by resazurin and trypan blue assay with IC50 values of 0.01 μg/ml and 0.64 μg/ ml at 72 h of treatment, respectively. Thus, the DNM50RL would play a vital role in the treatment of breast cancer targeting inhibition of p38MAPK. |
format |
article |
author |
Neelam Mishra Kavita Rana Siva Deepthi Seelam Rakesh Kumar Vijyendra Pandey Bharathi P. Salimath Bharathi P. Salimath Dayanand Agsar |
author_facet |
Neelam Mishra Kavita Rana Siva Deepthi Seelam Rakesh Kumar Vijyendra Pandey Bharathi P. Salimath Bharathi P. Salimath Dayanand Agsar |
author_sort |
Neelam Mishra |
title |
Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line |
title_short |
Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line |
title_full |
Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line |
title_fullStr |
Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line |
title_full_unstemmed |
Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line |
title_sort |
characterization and cytotoxicity of pseudomonas mediated rhamnolipids against breast cancer mda-mb-231 cell line |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/c6f867e64c444ad699994ee646e3e8d5 |
work_keys_str_mv |
AT neelammishra characterizationandcytotoxicityofpseudomonasmediatedrhamnolipidsagainstbreastcancermdamb231cellline AT kavitarana characterizationandcytotoxicityofpseudomonasmediatedrhamnolipidsagainstbreastcancermdamb231cellline AT sivadeepthiseelam characterizationandcytotoxicityofpseudomonasmediatedrhamnolipidsagainstbreastcancermdamb231cellline AT rakeshkumar characterizationandcytotoxicityofpseudomonasmediatedrhamnolipidsagainstbreastcancermdamb231cellline AT vijyendrapandey characterizationandcytotoxicityofpseudomonasmediatedrhamnolipidsagainstbreastcancermdamb231cellline AT bharathipsalimath characterizationandcytotoxicityofpseudomonasmediatedrhamnolipidsagainstbreastcancermdamb231cellline AT bharathipsalimath characterizationandcytotoxicityofpseudomonasmediatedrhamnolipidsagainstbreastcancermdamb231cellline AT dayanandagsar characterizationandcytotoxicityofpseudomonasmediatedrhamnolipidsagainstbreastcancermdamb231cellline |
_version_ |
1718404719608594432 |